GENE EXPRESSION MARKERS OF TUMOR RESISTANCE TO HER2 INHIBITOR TREATMENT

17-07-2018 дата публикации

Номер:

CA0002917355C

Автор: LEE-HOEFLICH, SI TUEN, STERN, HOWARD, LEE-HOEFLICH SI TUEN, STERN HOWARD

Принадлежит: GENENTECH, INC., GENENTECH INC

Контакты:

Номер заявки: 2917355

Дата заявки: 04-06-2008

The present invention concerns markers of resistance of HER2 expressing tumors to treatment with HER2 inhibitors, such as HER2 antibodies, including trastuzumab.

CPC - классификация

C C1 C12 C12Q C12Q1 C12Q1/C12Q1/6 C12Q1/68 C12Q1/688 C12Q1/6886 C12Q2 C12Q26 C12Q260 C12Q2600 C12Q2600/C12Q2600/1 C12Q2600/10 C12Q2600/106 C12Q2600/15 C12Q2600/158 G G0 G01 G01N G01N2 G01N23 G01N233 G01N2333 G01N2333/G01N2333/4 G01N2333/48 G01N2333/485 G01N28 G01N280 G01N2800 G01N2800/G01N2800/5 G01N2800/52 G01N3 G01N33 G01N33/G01N33/5 G01N33/57 G01N33/574 G01N33/5741 G01N33/57415

IPC - классификация

C C1 C12 C12Q C12Q1 C12Q1/C12Q1/6 C12Q1/68 C12Q1/680 C12Q1/6809 C12Q1/683 C12Q1/6837 C12Q1/688 C12Q1/6886 C4 C40 C40B C40B3 C40B30 C40B30/C40B30/0 C40B30/04 C40B4 C40B40 C40B40/C40B40/0 C40B40/06 G G0 G01 G01N G01N3 G01N33 G01N33/G01N33/4 G01N33/48 G01N33/5 G01N33/57 G01N33/574

Получить PDF